Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
NCT07142707

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Led by MBX Biosciences · Updated on 2026-04-28

124

Participants Needed

2

Research Sites

60 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the safety and tolerability of single and multiple subcutaneous (SC) doses of MBX 4291 in adults with obesity.

CONDITIONS

Official Title

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age of >18 to 65 years at the time of signing the informed consent.
  • Has a BMI of 630 to <50 kg/m2 at screening and baseline.
  • Weight-stable, i.e., no more than �15% change in body weight for at least 3 months prior to screening and between screening and baseline.
Not Eligible

You will not qualify if you...

  • History of, or currently active, significant illness or medical disorders that in the opinion of the investigator may preclude participants from participating in the study.
  • History of currently active pancreatitis, type I and type II diabetes.
  • Secondary causes of obesity, including but not limited to hypothalamic, monogenic, syndromic, or endocrine causes.
  • A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

MBX Biosciences Investigational Site

Lexington, Kentucky, United States, 40509

Actively Recruiting

2

MBX Biosciences Investigational Site

Knoxville, Tennessee, United States, 37920

Actively Recruiting

Loading map...

Research Team

E

Elisa Fabbrini, MD, PhD

CONTACT

S

Stewart Hallett

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here